136
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of a Novel Laboratory Candiduria Screening Protocol in the Intensive Care Unit

ORCID Icon, , , ORCID Icon, &
Pages 489-496 | Published online: 10 Feb 2021

References

  • Alfouzan WA, Dhar R. Candiduria: evidence-based approach to management, are we there yet? J Mycol Med. 2017;27(3):293–302. doi:10.1016/j.mycmed.2017.04.00528501465
  • Gajdács M, Dóczi I, Ábrók M, Lázár A, Burián K. Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey. Cent European J Urol. 2019;72(2):209–214. doi:10.5173/ceju.2019.1909
  • He Z, Liu Y, Wang T, Cheng Y, Chen J, Wang F. Candiduria in hospitalized patients: an investigation with the Sysmex UF-1000i urine analyzer. PeerJ. 2019;7:e6935. doi:10.7717/peerj.693531149401
  • Jain M, Dogra V, Mishra B, Thakur A, Loomba PS, Bhargava A. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J Pathol Microbiol. 2011;54(3):552–555. doi:10.4103/0377-4929.8509121934219
  • Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) mycoses study group. Clin Infect Dis. 2000;30(1):14–18. doi:10.1086/31358310619726
  • Bougnoux ME, Kac G, Aegerter P, CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008;34(2):292–299. doi:10.1007/s00134-007-0865-y17909746
  • Wang K, Hsueh K, Kronen R, et al. Creation and assessment of a clinical predictive model for candidaemia in patients with candiduria. Mycoses. 2019;62(7):554–561. doi:10.1111/myc.1291731025417
  • Drogari-Apiranthitou M, Anyfantis I, Galani I, Kanioura L, Daikos GL, Petrikkos G. Association between candiduria and candidemia: a clinical and molecular analysis of cases. Mycopathologia. 2017;182(11–12):1045–1052. doi:10.1007/s11046-017-0180-228744769
  • Pitarch A, Nombela C, Gil C. Diagnosis of invasive candidiasis: from gold standard methods to promising leading-edge technologies. Curr Top Med Chem. 2018;18(16):1375–1392. doi:10.2174/156802661866618102509314630360714
  • Gutiérrez-Fernández J, Riazzo C, Sanbonmatsu S, et al. Sysmex UF-1000i performance for screening yeasts in urine. APMIS. 2014;122(4):324–328. doi:10.1111/apm.1214823919730
  • Herráez O, Asencio MA, Carranza R, et al. Sysmex UF-1000i flow cytometer to screen urinary tract infections: the URISCAM multicentre study. Lett Appl Microbiol. 2018;66(3):175–181. doi:10.1111/lam.1283229223137
  • Le Z, Li F, Fei C, Ye A, Xie X, Zhang J. Performance of the Sysmex UF-1000i urine analyser in the rapid diagnosis of urinary tract infections in hospitalized patients. J Infect Chemother. 2016;22(6):377–382. doi:10.1016/j.jiac.2016.02.00927006323
  • Zhengxin H, Haipu Z, Yan C, et al. Performance of yeast-like cell counting (YLCC) using the Sysmex UF-1000i for clinical candiduria screening. Eur J Clin Microbiol Infect Dis. 2019;38(5):891–894. doi:10.1007/s10096-019-03491-530767096
  • Zhang J, Zhang C, Jia T, et al. Effect evaluation of MA 120 microbial identification and drug sensitivity analysis system in clinical microbiology identification and drug sensitivity test (in Chinese). Infect Dis Info. 2016;29(5):267–271.
  • De Rosa R, Grosso S, Lorenzi G, Bruschetta G, Camporese A. Evaluation of the new Sysmex UF-5000 fluorescence flow cytometry analyser for ruling out bacterial urinary tract infection and for prediction of Gram negative bacteria in urine cultures. Clin Chim Acta. 2018;484:171–178. doi:10.1016/j.cca.2018.05.04729803898
  • Ren C, Jin M, Wu J, Wang X, Wang Y, Cao H. Improving the detection of urine sediment with a modified urinalysis review procedure. Clin Lab. 2019;65(4). doi:10.7754/Clin.Lab.2018.180830
  • Aubron C, Suzuki S, Glassford NJ, Garcia-Alvarez M, Howden BP, Bellomo R. The epidemiology of bacteriuria and candiduria in critically ill patients. Epidemiol Infect. 2015;143(3):653–662. doi:10.1017/S095026881400093424762978
  • Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis. 2005;40(10):1413–1421. doi:10.1086/42962015844063
  • Falahati M, Farahyar S, Akhlaghi L, et al. Characterization and identification of candiduria due to Candida species in diabetic patients. Curr Med Mycol. 2016;2(3):10–14. doi:10.18869/acadpub.cmm.2.3.1028681023
  • He Z, Huo X, Lei D, Zhao H, Jia K, Wang F. Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions [published online ahead of print, 2020 Jul 30]. Eur J Clin Microbiol Infect Dis. 2020;40:59–65. doi:10.1007/s10096-020-03999-1.32734337
  • Kumar S, Singhi S, Chakrabarti A, Bansal A, Jayashree M. Probiotic use and prevalence of candidemia and candiduria in a PICU. Pediatr Crit Care Med. 2013;14(9):e409–e415. doi:10.1097/PCC.0b013e31829f5d8823965638
  • Padawer D, Pastukh N, Nitzan O, et al. Catheter-associated candiduria: risk factors, medical interventions, and antifungal susceptibility. Am J Infect Control. 2015;43(7):e19–e22. doi:10.1016/j.ajic.2015.03.01325920705
  • Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WM. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma. 1993;35(2):290–295. doi:10.1097/00005373-199308000-000208355311
  • Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections–epidemiology. Clin Infect Dis. 2011;52(Suppl 6):S433–S436. doi:10.1093/cid/cir10921498836
  • García-Agudo L, Rodríguez-Iglesias M, Carranza-González R. Nosocomial candiduria in the elderly: microbiological diagnosis. Mycopathologia. 2018;183(3):591–596. doi:10.1007/s11046-017-0232-729196922
  • Negri M, Silva S, Henriques M, Oliveira R. Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis. 2012;31(7):1399–1412. doi:10.1007/s10096-011-1455-z22037823
  • Santana MMP, Hoffmann-Santos HD, Dias LB, et al. Epidemiological profile of patients hospitalized with candiduria in the Central-Western region of Brazil. Rev Iberoam Micol. 2019;36(4):175–180. doi:10.1016/j.riam.2019.04.00631699523
  • Lau AF, Kabir M, Chen SC, et al. Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol. J Clin Microbiol. 2015;53(4):1324–1330. doi:10.1128/JCM.03239-1425673797
  • Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med. 2014;40(10):1429–1448. doi:10.1007/s00134-014-3355-z24934813
  • Caggiano G, Puntillo F, Coretti C, et al. Candida colonization index in patients admitted to an ICU. Int J Mol Sci. 2011;12(10):7038–7047. doi:10.3390/ijms1210703822072934
  • León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730–737. doi:10.1097/01.CCM.0000202208.37364.7D16505659